Company Filing History:
1 out of 3 
1 out of 2 
1 out of 1 Years Active: 2017
Title: Karolina Drazkowska: Innovator in Cancer Treatment
Introduction
Karolina Drazkowska is a prominent inventor based in Warsaw, Poland. She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic agents. Her work focuses on the selection of hDIS3 PIN domain inhibitors, which hold promise for treating various cancers.
Latest Patents
Karolina Drazkowska holds a patent for a method related to the selection of hDIS3 PIN domain inhibitors and their application in cancer treatment. The patent, titled "Method for selection of hDIS3 PIN domain inhibitors and use of hDIS3 PIN domain inhibitors for cancer treatment," describes a method for screening these inhibitors, as well as the yeast strain and cell line used in such methods. This invention also introduces new therapeutic agents selected as hDIS3 PIN domain inhibitors, which can be utilized in treating cancers with mutations in the hDIS3 RNB domain, particularly multiple myeloma. Additionally, the patent discusses a composition comprising the new therapeutic agent and a method for inducing synthetic lethality in cancer cells.
Career Highlights
Throughout her career, Karolina has worked with notable institutions, including the Institute of Biochemistry and Biophysics of the Polish Academy of Sciences and Oncoarendi Therapeutics Sp. z o.o. Her research has been pivotal in advancing the understanding of cancer treatment methodologies.
Collaborations
Karolina has collaborated with esteemed colleagues such as Andrzej Dziembowski and Rafal Tomecki. Their joint efforts have contributed to the development of innovative solutions in the field of cancer research.
Conclusion
Karolina Drazkowska is a trailblazer in the realm of cancer treatment, with her patent and collaborative efforts paving the way for new therapeutic approaches. Her work exemplifies the impact of innovation in addressing critical health challenges.